PROFOUND MEDICAL CORP (PROF) Stock Analyst Ratings

NASDAQ:PROF • CA74319B5027

7.61 USD
-0.17 (-2.12%)
At close: Feb 27, 2026
7.61 USD
0 (0%)
After Hours: 2/27/2026, 8:27:38 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to PROF. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 11.6. This target is 52.4% above the current price.
  • PROF was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about PROF.
  • In the previous month the buy percentage consensus was at a similar level.
  • Only 5 analysts analyzed PROF. So this is just the average opinion of a couple of analysts.

Related screens

Find peers with buy consensus above 85%
PROF Historical Analyst RatingsPROF Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 1 2 3 4 5

Price Target & Forecast

Price Low Median Mean High 7.6111.4811.6011.6011.94 - 50.90% 52.40% 52.40% 56.88%

Related screens

Find peers 30% below price target
PROF Current Analyst RatingPROF Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2026-01-07 Lake Street Maintains Buy -> Buy
2025-04-23 Lake Street Maintains Buy -> Buy
2024-07-16 Stifel Upgrade Hold -> Buy
2024-03-11 Alliance Global Partners Maintains Buy -> Buy
2024-03-08 Stifel Maintains Hold -> Hold
2024-01-04 Alliance Global Partners Maintains Buy -> Buy
2023-11-28 Stifel Initiate Hold
2023-08-04 Raymond James Downgrade Strong Buy -> Outperform
2023-05-11 TD Cowen Maintains Outperform
2023-05-11 Alliance Global Partners Maintains Buy
2023-03-21 Jefferies Downgrade Buy -> Equal-Weight
2022-11-04 Raymond James Upgrade Outperform -> Strong Buy
2022-03-07 Cowen & Co. Maintains Outperform
2022-02-22 Raymond James Downgrade Strong Buy -> Outperform
2021-07-28 Raymond James Financial Initiate Strong Buy
2021-05-13 Raymond James Financial Upgrade Strong-Buy
2021-03-10 Raymond James Financial Initiate STRONG BUY
2021-02-26 Raymond James Financial Reiterate Strong Buy

PROFOUND MEDICAL CORP / PROF FAQ

What is the price target for PROF stock?

5 analysts have analysed PROF and the average price target is 11.6 USD. This implies a price increase of 52.4% is expected in the next year compared to the current price of 7.61.


How do analysts rate PROFOUND MEDICAL CORP (PROF)?

The consensus rating for PROFOUND MEDICAL CORP (PROF) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.